Condition: Prostate Cancer · Sponsor: Karolinska Institutet
Interested? Contact the study team ↓
It is evident that patients receiving treatment for cancer have symptoms that often are undetected. Furthermore, many survivors from cancer have ongoing poor health and well-being and long-term rehabilitation and support should not be neglected to prevent recurrence and increase survival. There are good reasons to believe that routine collection of relevant patient-reported symptoms facilitates person-centered care where the patient is a participatory member of the team. This study aims to pilot-test a supportive intervention in primary care for six months during the first year after primary treatment for prostate cancer in primary care and compare it to standard care only. The intervention consists of symptom reporting and self-management in an app in combination with health dialogues with a study-specific nurse at a primary care centre.
This description comes directly from the study's public registry record.
Nazmije Kelmendi, PHDstudent · 0046-702677869 · nazmije.kelmendi@ki.se
Ann Langius-Eklöf, Professor · 0046-704315878 · ann.langius-eklof@ki.se
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * patients with prostate cancer at the end of curative treatment * able to read and understand Swedish * considered being physically, psychologically and cognitively able to participate in the study
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Health Care Services Stockholm County (SLSO) | Stockholm, Sweden | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.